newsfilter
← Latest News
Business Wire·

PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society

PepGen Inc. (NASDAQ:PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases,